Scroll to top
Tag: dissemination

Dartmouth to Host Summit on Digital Therapeutics

Article Excerpt: The Center for Technology and Behavioral Health will host its second digital health summit on Oct. 25 at the Hanover Inn. The Clinically-Validated Digital Therapeutics: Innovations in Scientific Discovery, Clinical Applications, and Global Deployment event will gather experts from diverse sectors of the health care industry—researchers, providers, regulators, payers, and investors, as well as representatives from global pharma—to help shape a vision for making digital therapeutics accessible to all.

“The goal of the summit is to bring together a really broad group of stakeholders in the space of digital health, and have a shared dialogue about where are we at this moment in time and how we can work together to accelerate the pace at which we can get the most effective and most engaging tools into the hands of people all over the world,” says CTBH Director Lisa Marsch.

Full Article:

Article Source: Dartmouth News


Digital Therapeutics Summit Held at Dartmouth

Article Excerpt: Nearly 175 people representing the digital health and pharmaceutical industries, health care systems, clinicians, scientists, investors, Dartmouth students and faculty, and government officials representing the National Institutes of Health (NIH) and the U.S. Food and Drug Administration (FDA) gathered on Dartmouth’s campus November 2 for daylong discussions centered on digital therapeutics. Hosted by Geisel School of Medicine’s Center for Technology and Behavioral Health (CTBH) and Dartmouth’s Magnuson Center for Entrepreneurship, the program provided an overview of the science and clinical practice of digital therapeutics, the current and anticipated paths to their global deployment, and a vision for the future. This is the first time these groups have come together in conversations hosted by an academic institution about the digital health landscape and may well be viewed as a seminal moment in the rapidly developing field.

Full Article:

Article Source: Dartmouth Geisel School of Medicine News


FAST: A Framework to Assess Speed of Translation of Health Innovations to Practice and Policy

Proctor E, Ramsey AT, Saldana L, Maddox TM, Chambers DA, Brownson RC. FAST: A Framework to Assess Speed of Translation of Health Innovations to Practice and Policy. Glob Implement Res Appl. 2022;2(2):107-119. doi:10.1007/s43477-022-00045-4

A known challenge for translational research is the gap of time from discovery to practical application into routine public health practice or clinical care. This paper offers a first step to conducting research on implementation speed and aims to understand the complexities of implementation speed, offer a framework to assess speed of translation (FAST), and provide guidance on how to measure speed in evaluating implementation efforts. First, the paper discussed different perspectives on the optimal pace of implementation processes and the balance of risks and benefits related to slower or quicker implementation. The benefits for quicker implementation are responding rapidly to health and social crises, applying an anticipatory approach to social and health service systems, and addressing healthcare and social inequities in prevention and care. The benefit of slower implementation is ensuring there is adequate evidence for safe and successful implementation. Three complex factors were identified that should be considered in studying implementation speed: (1) varying stakeholders’ priorities for speed, (2) what referent is speed being measured, and (3) observation time windows in research studies. To address these complexities and challenges, the authors proposed a Framework to Assess Speed of Translation (FAST) to guide research and inform a set of parameters and metrics for capturing speed, factors that affect speed, and the effects of speed on implementation. Future research is needed to describe speed and develop metrics, examine innovation, adopter, and contextual influences, identify specific strategies to accelerate speed, assess the effect of implementation speed on outcomes, and develop designs for testing speed.


Patient Engagement: The True Benchmark in Clinical Trials

Article Excerpt: Patient engagement and community outreach may be hot topics in today’s clinical trial landscape, but they aren’t new ideas. Researchers and patient advocacy groups have focused on including patients and volunteers in study design and data reporting for many years. What’s new is the vital role technology plays in engagement as decentralized clinical trials become more popular.

Full Article:

Article Source: Stat News


Geisel’s Center for Technology and Behavioral Health $7.1M Grant to Expand Work in Digital Therapeutics

Article Excerpt: The Geisel School of Medicine at Dartmouth’s Center for Technology and Behavioral Health (CTBH) has received a five-year renewal grant of more than $7.1 million from The National Institute on Drug Abuse (NIDA), an institute under the National Institutes of Health dedicated to supporting scientific research on drug use and its consequences. “I’m very excited for Dr. Marsch and her colleagues in the Center for Technology and Behavioral Health to receive this renewed support to pursue improvements to treating substance use disorders,” says Geisel’s dean Duane A. Compton, PhD. “The digital tools developed by CTBH, and its collaborative partners, provide ongoing innovative approaches to help individuals in need manage their disorder.”

Full Article:

Article Source: Geisel School of Medicine News


FDA Unveils Campaign to Support Tobacco Smokers Quit Smoking

Article Excerpt: The Food and Drugs Authority (FDA) has launched a year-long campaign dubbed: “Commit to Quit,” aimed at supporting tobacco smokers to abandon smoking as it poses enormous health hazards on their wellbeing. Activities of the campaign will include rolling out of routine public education in schools, market places and transport terminals to serve as a platform for speaking on specific challenges smokers encounter in their quest to quit tobacco smoking. The crusade would advocate stronger tobacco cessation policies, increase access to cessation services, raise awareness of tobacco industry tactics and empower smokers to make successful quit attempts through “quit and win” initiatives.

Full Article:

Article Source: Ghana Web


Facebook, Twitter, Google Join Hands To Support Drug Addiction Recovery

Article Excerpt: In a bid to support individuals with substance abuse and drug addiction during COVID-19 times, Google, Facebook and Twitter have joined non-profit Center for Safe Internet Pharmacies (CSIP) to launch an initiative called Tech Together.

Full Article:

Article Source: Telangana Today


Technology Companies Come Together to Support Addiction Recovery During COVID-19

Article Excerpt: The Center for Safe Internet Pharmacies (CSIP) – a non-profit dedicated to consumer protection and education around online pharmacies and prescription drugs – and a coalition of tech leaders Google, Facebook and Twitter have joined forces to announce a new online platform The site is a collection of resources to help those experiencing substance use disorder or battling addiction and the associated stigma.

Full Article:

Article Source: Yahoo Finance


Can Siri Help You Beat Addiction?

Article Excerpt: Can a smart assistant help you beat addiction? That’s the questions asked in a new study by researchers at he Center for Data Driven Health at the Qualcomm Institute within the University of California San Diego. The study concludes that devices like Amazon Alexa, Apple Siri, Google Assistant, Microsoft Cortana, and Samsung Bixby fail to help users with such problems, but highlight these devices potential for signposting in the future.

Full Article:

Article Source: Technology Networks